{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T09:35:51Z","timestamp":1648892151434},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The novel coronavirus disease 2019 has grown to be a global public health emergency. The rapid spread of the infection has raised many questions in the oncohematological scientific community regarding the appropriateness of high-dose chemotherapy with autologous stem cell transplantation (ASCT). We here report two cases of patients who received ASCT at our Institute during the epidemic in Italy, affected with Hodgkin lymphoma and germ cell tumor, respectively. The two patients underwent a nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on hospital admittance and during the period of bone marrow aplasia. They were attended to exclusively by dedicated health care staff who followed specifically implemented protocols for bedside nursing and care. They completed the procedure without unexpected side effect. Our experience demonstrates how ASCT can be performed safely if procedures are reorganized ad hoc to reduce the risk of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.1002\/onco.13563","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T19:24:22Z","timestamp":1602530662000},"page":"e336-e337","source":"Crossref","is-referenced-by-count":2,"title":["To Transplant or Not to Transplant During the SARS-CoV-2 Pandemic? That Is the Question"],"prefix":"10.1093","volume":"26","author":[{"given":"Dario","family":"Marino","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Finotto","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Basso","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Galiano","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maital","family":"Bolshinsky","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavia","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Marson","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, University Hospital of Padua, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Tison","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, University Hospital of Padua, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Colpo","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, University Hospital of Padua, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorina","family":"Zagonel","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology (IOV), Istituto Ricerca Cura Carattere Scientifico, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"2021122511555273600_onco13563-bib-0001","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bbmt.2020.04.005","article-title":"American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group position statement on pharmacy practice management and clinical management for COVID-19 in hematopoietic cell transplantation and cellular therapy patients in the United States","volume":"26","author":"Mahmoudjafari","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122511555273600_onco13563-bib-0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bjh.16597","article-title":"How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?","volume":"189","author":"Dholaria","year":"2020","journal-title":"Br J Haematol"},{"key":"2021122511555273600_onco13563-bib-0003"},{"key":"2021122511555273600_onco13563-bib-0004","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study","volume":"127","author":"Barrington","year":"2016","journal-title":"Blood"},{"key":"2021122511555273600_onco13563-bib-0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","author":"International Germ Cell Cancer Collaborative Group","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021122511555273600_onco13563-bib-0006","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.32628","article-title":"High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases","volume":"126","author":"Kalra","year":"2020","journal-title":"Cancer"},{"key":"2021122511555273600_onco13563-bib-0007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/bjh.16699","article-title":"How we deal with the COVID-19 epidemic in an Italian paediatric onco-haematology clinic located in a region with a high density of cases","volume":"189","author":"Sainati","year":"2020","journal-title":"Br J Haematol"},{"key":"2021122511555273600_onco13563-bib-0008","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMsb2005114","article-title":"Fair allocation of scarce medical resources in the time of COVID-19","volume":"382","author":"Emanuel","year":"2020","journal-title":"N Engl J Med"},{"key":"2021122511555273600_onco13563-bib-0009","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"2021122511555273600_onco13563-bib-0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/onco.13563","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/onco.13563","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/2\/e336\/41923392\/oncolo_26_2_e336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/2\/e336\/41923392\/oncolo_26_2_e336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T11:59:28Z","timestamp":1640433568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/26\/2\/e336\/6445366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,10,23]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/onco.13563","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,10,23]]}}}